The Jordanian Pharmaceutical Manufacturing Company - Public Shareholding Company (ASE:JPHM)

ASE:JPHM Balance Sheet

Financials in millions JOD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	0.13	0.05	0.62	2.61	11.43	0.21
Cash & Short-Term Investments	0.13	0.05	0.62	2.61	11.43	0.21
Cash Growth	28.74%	-91.91%	-76.39%	-77.18%	5383.24%	-53.76%
Accounts Receivable	11.22	13.75	14.28	17.67	15.34	16.52
Other Receivables	2.19	2.26	1.26	1.25	0.69	0.1
Receivables	13.41	16.01	15.54	18.92	16.02	16.62
Inventory	7.12	6.11	6.62	6.52	5.62	6.1
Prepaid Expenses	-	0.3	0.32	0.3	0.14	0.06
Other Current Assets	0.55	0.47	0.55	1.05	0.42	0.68
Total Current Assets	21.21	22.94	23.64	29.39	33.63	23.68
Property, Plant & Equipment	17.18	17.68	11.54	11.29	10.95	11.24
Long-Term Investments	4.56	4.56	3.96	3.73	3.16	3.27
Other Intangible Assets	2.29	2.09	2.11	2.06	2.06	2.06
Long-Term Deferred Tax Assets	0.99	0.99	1.23	1.37	-	-
Total Assets	46.23	48.27	42.49	47.84	49.81	40.25

Liabilities

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Accounts Payable	4.16	3.71	2.45	2.8	2.41	2.59
Accrued Expenses	0.34	3.34	3.3	3.7	5.7	3.92
Short-Term Debt	-	-	-	-	0.95	0.96
Current Portion of Long-Term Debt	4.72	8.95	2.57	2.91	2.07	7.91
Current Portion of Leases	-	-	0.64	0.54	0.65	0.61
Current Income Taxes Payable	0.66	0	0.01	0.06	0.06	-
Current Unearned Revenue	-	-	0.11	0.11	0.11	0.11
Other Current Liabilities	4.77	2.84	2.55	2.36	1.42	8
Total Current Liabilities	14.65	18.84	11.62	12.49	13.37	24.1
Long-Term Debt	23.63	23.81	24.48	25.48	26.31	17.55
Long-Term Leases	-	-	5.99	6.5	6.97	7.4
Long-Term Unearned Revenue	-	-	0.98	1.09	1.21	1.32
Other Long-Term Liabilities	0	0	-	-	-	-
Total Liabilities	38.28	42.65	43.06	45.56	47.86	50.37

Shareholders' Equity

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Common Stock	33.7	33.7	69.76	69.76	25.31	25.31
Retained Earnings	3.33	0.86	-35.84	-32.99	-33.05	-33.17
Comprehensive Income & Other	-29.08	-29.08	-34.64	-34.64	9.59	-2.39
Total Common Equity	7.95	5.48	-0.73	2.13	1.85	-10.25
Minority Interest	0	0.14	0.16	0.15	0.11	0.14
Shareholders' Equity	7.95	5.62	-0.57	2.28	1.95	-10.12
Total Liabilities & Equity	46.23	48.27	42.49	47.84	49.81	40.25

Additional Metrics

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Total Debt	28.35	32.76	33.67	35.43	36.94	34.43
Net Cash (Debt)	-28.22	-32.71	-33.05	-32.82	-25.51	-34.22
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-0.84	-0.97	-0.98	-0.48	-0.37	-1.35
Filing Date Shares Outstanding	33.7	33.7	69.76	69.76	25.31	25.31
Total Common Shares Outstanding	33.7	33.7	69.76	69.76	25.31	25.31
Working Capital	6.56	4.1	12.02	16.9	20.26	-0.42
Book Value Per Share	0.24	0.16	-0.01	0.03	0.07	-0.41
Tangible Book Value	5.66	3.39	-2.84	0.07	-0.21	-12.32
Tangible Book Value Per Share	0.17	0.10	-0.04	0.00	-0.01	-0.49
Land	-	7.81	0.49	0.49	0.49	0.49
Buildings	-	11.5	3.93	3.93	3.87	3.87
Machinery	-	18.16	16.92	15.92	15.1	14.82

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 30, 2026

Data Sources Report a data error